The Prescription Drug Problem & PBM Reform
June 04, 2024
Senators push Commerce Department to finalize rules on lowering drug pricesThe proposal would help boost competition and reduce prices for American families by allowing the federal government to step in when private actors.
June 06, 2024
Weighty decisions: GLP-1 considerations during benefits renewal seasonWhile the public may view these drugs as a silver bullet solution, there is also a cloud of potential misinformation regarding who should use them, possible side effects, and other long-term risks and successes.
June 11, 2024
Patient health may be at risk as drug shortages become more widespread, research findsDrugs with higher manufacturing complexity, such as sterile injectables, are more vulnerable to shortages.
June 12, 2024
Drugmakers frequently pay physicians to endorse products on social media, study findsTwenty-six of the 28 physicians included in the study received payments from pharmaceutical companies for a variety of reasons, most often noted as food and beverages, speaking or consulting fees.
June 13, 2024
Supreme Court upholds full access to abortion pill mifepristone, in unanimous rulingIn a major victory today for the Biden administration, the high court has upheld broad access to mifepristone, the widely used abortion pill, overturning an appeals court ruling that barred mail-order prescriptions.
June 14, 2024
Increasing number of employers covering GLP-1 drugs for weight loss, survey findsOf those that currently offer coverage only for diabetes, 19% are considering offering the drugs for weight loss as well.
June 18, 2024
Drug patent bill could cut the federal deficit by $3B, analysts predictThe Affordable Prescriptions for Patients Act would keep manufacturers from tweaking products to maintain patent protection.
June 20, 2024
The Supreme Court's Mifepristone ruling & its implications for self-funded health plansThis decision leaves the door open for other plaintiffs who may bring a similar challenge against the FDA and mifepristone in the future.
June 20, 2024
Health platform now offering compounded Ozempic and Wegovy at reduced pricesWhile shortages of the popular weight loss drugs persist, Hims & Hers, a San Francisco-based telehealth company, will offer access to a compounded form of the GLP-1 weight-loss drugs, starting at $199 a month.
June 21, 2024
UnitedHealth unit to pay New York $1M over birth control step therapy moveA state law requires carriers to cover all FDA-approved contraceptives without cost-sharing or restrictions.